Adaptive Biotechnologies Corp Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp for January 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Sell | S | 24.98 | 4,912,899 | 122,706,039 | 33,493,708 | 38.4 M to 33.5 M (-12.79 %) |
| Jan 30 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | S | 24.98 | 4,912,899 | 122,706,039 | 33,493,708 | 38.4 M to 33.5 M (-12.79 %) |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 746,400 | |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 757,600 | |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 768,800 | |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 30.99 | 11,120 | 344,609 | 1,878,180 | 1.9 M to 1.9 M (-0.59 %) |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 31.90 | 800 | 25,520 | 1,878,180 | 1.9 M to 1.9 M (-0.04 %) |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 31.08 | 10,320 | 320,746 | 1,878,980 | 1.9 M to 1.9 M (-0.55 %) |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 30.01 | 11,120 | 333,711 | 1,878,180 | 1.9 M to 1.9 M (-0.59 %) |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Option Exercise | M | 0.16 | 100,000 | 16,000 | 0 | |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Sell | S | 26.50 | 345,000 | 9,142,500 | 3,621,016 | 4 M to 3.6 M (-8.70 %) |
| Jan 29 2020 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Buy | M | 0.16 | 100,000 | 16,000 | 3,966,016 | 3.9 M to 4 M (+2.59 %) |
| Jan 28 2020 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Sell | C | 26.50 | 2,217,101 | 58,753,177 | 15,115,090 | 17.3 M to 15.1 M (-12.79 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,700 | 23,384 | 588,900 | |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,700 | 23,384 | 592,600 | |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,700 | 23,384 | 596,300 | |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 28.30 | 2,400 | 67,920 | 70,679 | 73.1 K to 70.7 K (-3.28 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 27.33 | 1,300 | 35,529 | 73,079 | 74.4 K to 73.1 K (-1.75 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,700 | 23,384 | 74,379 | 70.7 K to 74.4 K (+5.23 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 29.54 | 1,300 | 38,402 | 70,679 | 72 K to 70.7 K (-1.81 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 28.98 | 1,300 | 37,674 | 71,979 | 73.3 K to 72 K (-1.77 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 27.80 | 1,100 | 30,580 | 73,279 | 74.4 K to 73.3 K (-1.48 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,700 | 23,384 | 74,379 | 70.7 K to 74.4 K (+5.23 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 29.52 | 3,700 | 109,224 | 70,679 | 74.4 K to 70.7 K (-4.97 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,700 | 23,384 | 74,379 | 70.7 K to 74.4 K (+5.23 %) |
| Jan 10 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 662 | 4,336 | 50,000 | |
| Jan 10 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 30.00 | 662 | 19,860 | 1,300 | 2 K to 1.3 K (-33.74 %) |
| Jan 10 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 662 | 4,336 | 1,962 | 1.3 K to 2 K (+50.92 %) |
| Jan 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 4.07 | 20,000 | 81,400 | 80,000 | |
| Jan 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 29.87 | 20,000 | 597,400 | 1,000 | 21 K to 1,000 (-95.24 %) |
| Jan 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 4.07 | 20,000 | 81,400 | 21,000 | 1,000 to 21 K (+2,000.00 %) |
| Jan 07 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | SVP, Operations | Option Exercise | M | 0.84 | 60,000 | 50,400 | 140,000 | |
| Jan 07 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | SVP, Operations | Sell | S | 29.14 | 60,000 | 1,748,400 | 10,000 | 70 K to 10 K (-85.71 %) |
| Jan 07 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | SVP, Operations | Buy | M | 0.84 | 60,000 | 50,400 | 70,000 | 10 K to 70 K (+600.00 %) |
| Jan 07 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | SVP, Operations | Option Exercise | M | 0.84 | 60,000 | 50,400 | 140,000 | |
| Jan 07 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | SVP, Operations | Sell | S | 29.14 | 60,000 | 1,748,400 | 10,000 | 70 K to 10 K (-85.71 %) |
| Jan 07 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | SVP, Operations | Buy | M | 0.84 | 60,000 | 50,400 | 70,000 | 10 K to 70 K (+600.00 %) |